Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder that is caused by mutations at two loci, polycystin 1 (PKD1) and polycystin 2 (PKD2). It is characterized by the formation of multiple cysts in the kidneys that can lead to chronic renal failure. Previous studies have suggested a role for hyperactivation of mammalian target of rapamycin (mTOR) in cystogenesis, but the etiology of mTOR hyperactivation has not been fully elucidated. In this report we have shown that mTOR is hyperactivated in Pkd1-null mouse cells due to failure of the HGF receptor c-Met to be properly ubiquitinated and subsequently degraded after stimulation by HGF. In Pkd1-null cells, Casitas B-lineage lymphoma (c-Cbl), an E3-ubiquitin ligase for c-Met, was sequestered in the Golgi apparatus with α₃β₁ integrin, resulting in the inability to ubiquitinate c-Met. Treatment of mouse Pkd1-null cystic kidneys in organ culture with a c-Met pharmacological inhibitor resulted in inhibition of mTOR activity and blocked cystogenesis in this mouse model of ADPKD. We therefore suggest that blockade of c-Met is a potential novel therapeutic approach to the treatment of ADPKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“transplantation to reconstitute the brain with wild-type microglia reverses somatic phenotypes, neuropathological changes, and behavioural abnormalities in two mouse models of ASD — MeCP2−/y model of Rett syndrome232 and the MIA model132.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [232]
Citations
Cites
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Expression of the c-ret proto-oncogene during mouse embryogenesis
Pachnis, V., Mankoo, B., & Costantini, F. (1993) · Development · doi:10.1242/dev.119.4.1005 · Cited by 837
Shillingford, J. M., Murcia, N. S., Larson, C. H., Low, S. H., Hedgepeth, R., Brown, N., Flask, C. A., Novick, A. C., Goldfarb, D. A., Kramer-Zucker, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509694103 · Cited by 808
Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis
Kreidberg, J. A., Donovan, M. J., Goldstein, S. L., Rennke, H., Shepherd, K., Jones, R. C., & Jaenisch, R. (1996) · Development · doi:10.1242/dev.122.11.3537 · Cited by 723
Self-citationBalch, W. E., Dunphy, W. G., Braell, W. A., & Rothman, J. E. (1984) · Cell · doi:10.1016/0092-8674(84)90019-9 · Cited by 696
Defective planar cell polarity in polycystic kidney disease
Fischer, E., Legue, E., Doyen, A., Nato, F., Nicolas, J.-F., Torres, V., Yaniv, M., & Pontoglio, M. (2006) · Nature Genetics · doi:10.1038/ng1701 · Cited by 537
Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease
Saburi, S., Hester, I., Fischer, E., Pontoglio, M., Eremina, V., Gessler, M., Quaggin, S. E., Harrison, R., Mount, R., & McNeill, H. (2008) · Nature Genetics · doi:10.1038/ng.179 · Cited by 525
Follit, J. A., Tuft, R. A., Fogarty, K. E., & Pazour, G. J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-02-0133 · Cited by 498
Nauli, S. M., Kawanabe, Y., Kaminski, J. J., Pearce, W. J., Ingber, D. E., & Zhou, J. (2008) · Circulation · doi:10.1161/circulationaha.107.710111 · Cited by 466
Self-citation
Research works printed but not linked: 5
- Takayama, 1997, Lab Invest., 77, 131
- Lanoix, 1996, Oncogene., 13, 1153
- Ehara, 1994, Am J Pathol., 144, 612
- Carone, 1993, Lab Invest., 68, 413
- Girod, 1980, C R Seances Acad Sci D., 290, 711
Cited by
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Signaling through the Primary Cilium
Wheway, G., Nazlamova, L., & Hancock, J. T. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00008 · Cited by 483
“Other studies in the Pkd1 mouse showed that mTOR hyperactivation was due to a failure of ubiquitination of c-met, a hepatocyte growth factor receptor (Qin et al., 2010).”
BackgroundPyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
Takakura, A., Nelson, E. A., Haque, N., Humphreys, B. D., Zandi-Nejad, K., Frank, D. A., & Zhou, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr338 · Cited by 143
Self-citationChristensen, S. T., Morthorst, S. K., Mogensen, J. B., & Pedersen, L. B. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028167 · Cited by 125
“Polycystin signaling may also involve interaction with another RTK, c-Met, which was shown in mouse kidney cells to rely on polycystin 1 for appropriate ubiquitylation and signaling down-regulation in response to stimulation with the c-Met ligand, hepatocyte growth factor (HGF) (Qin et al. 2010).”
BackgroundMuto, Y., Dixon, E. E., Yoshimura, Y., Wu, H., Omachi, K., Ledru, N., Wilson, P. C., King, A. J., Olson, N. E., Gunawan, M. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34255-z · Cited by 128
Metadata
- Authors
- Qin, S., Taglienti, M., Nauli, S. M., Contrino, L., Takakura, A., Zhou, J., & Kreidberg, J. A.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2010-10-01
- Volume
- 120
- Issue
- 10
- Pages
- 3617-3628
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2947217
- OpenAlex
- W2055349890
- Cited by
- 70
- References
- 67
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 9
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Chapman University Digital Commons (Chapman University) (submittedVersion)
- Funders
- American Heart Association
- PKD Foundation
- National Institutes of Health (DK51050)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK50118-01, DK 40703, P50DK074030, DK 51050, R01DK050118, DK074030, R37DK051050, R01DK051050, R01DK040703)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- autosomal dominant polycystic kidney disease, c-Met, mTOR signaling, ubiquitination, polycystin-1, polycystin-2, c-Cbl, E3 ubiquitin ligase, HGF receptor, alpha3beta1 integrin, Golgi apparatus, cyst formation, c-Met inhibitor, therapeutic target
- MeSH terms
- Animals, Cell Line, Cilia, Disease Models, Animal, Glycosylation, Golgi Apparatus, Morphogenesis, Signal Transduction, Polycystic Kidney, Autosomal Dominant, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins c-met, Integrin alpha3beta1, Intracellular Signaling Peptides and Proteins, TRPP Cation Channels, Proto-Oncogene Proteins c-cbl, Mice, Ubiquitination, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. https://app.cochat.ai/papers/10.1172/jci41531
- The paper
- Qin, S., Taglienti, M., Nauli, S. M., Contrino, L., Takakura, A., Zhou, J., & Kreidberg, J. A. (2010). Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci41531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.